Improving life for cancer patients through transformative drugs

Play

News

2018/10/17

Medivir scales back research costs to focus on clinical development

Read more
2018/10/15

Medivir to focus on its clinical development and appoints Uli Hacksell as acting CEO

Read more
2018/10/04

Positive interim data on birinapant in combination with Keytruda®

Read more

Partner with Medivir

Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.